Marshall Wace, LLP Becton Dickinson & CO Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall Wace, LLP holds 669,572 shares of BDX stock, worth $156 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
669,572
Previous 11,093
5935.99%
Holding current value
$156 Million
Previous $2.7 Million
6027.4%
% of portfolio
0.26%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding BDX
# of Institutions
1,728Shares Held
240MCall Options Held
640KPut Options Held
766K-
Vanguard Group Inc Valley Forge, PA26.2MShares$6.12 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$5.33 Billion0.13% of portfolio
-
State Street Corp Boston, MA13.5MShares$3.16 Billion0.15% of portfolio
-
Morgan Stanley New York, NY10.7MShares$2.5 Billion0.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.1MShares$2.37 Billion0.31% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $66.7B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...